Enveric Biosciences, Inc. (NASDAQ:ENVB – Get Free Report) was the recipient of a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 150,400 shares, a growth of 58.1% from the February 29th total of 95,100 shares. Approximately 3.2% of the company’s shares are sold short. […]